Business Description
China NT Pharma Group Co Ltd
ISIN : KYG2114L1059
Total Employee Number:
22Compare
Compare
Traded in other countries / regions
01011.Hong Kong IPO Date
2011-04-20Description
China NT Pharma Group Co Ltd is a technology-based pharmaceutical company. It is engaged in research and development, production, and sale of private-label drugs, as well as the provision of pharmaceutical marketing and promotion services in China. It focused on the research, development, production, and sales of orthopedic, psychiatric, and oncology drugs. The Group's operations are regarded as having two operating and reportable segments, namely Agency Services and Healthcare Related Services. The company generates maximum of its revenue from Healthcare Related Services.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.04 | |||||
Equity-to-Asset | -0.17 | |||||
Debt-to-Equity | -3.01 | |||||
Debt-to-EBITDA | 13361.76 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | -12.07 | |||||
Beneish M-Score | 136.55 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -59.7 | |||||
3-Year EPS without NRI Growth Rate | 39.4 | |||||
3-Year Book Growth Rate | 31.9 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 67 | |||||
9-Day RSI | 65.01 | |||||
14-Day RSI | 61.61 | |||||
3-1 Month Momentum % | -30.56 | |||||
6-1 Month Momentum % | -50.66 | |||||
12-1 Month Momentum % | -52.53 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.05 | |||||
Quick Ratio | 0.04 | |||||
Cash Ratio | 0.02 | |||||
Days Inventory | 12.13 | |||||
Days Sales Outstanding | 123.09 | |||||
Days Payable | 55.93 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -52.4 | |||||
Shareholder Yield % | 12.37 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 18.6 | |||||
Operating Margin % | -37.74 | |||||
Net Margin % | -71.6 | |||||
EBITDA Margin % | 0.07 | |||||
FCF Margin % | -14.04 | |||||
OCF Margin % | -14.04 | |||||
ROA % | -5.83 | |||||
ROIC % | -1.55 | |||||
3-Year ROIIC % | -1.26 | |||||
ROC (Joel Greenblatt) % | 1.31 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 7.92 | |||||
EV-to-EBIT | 29944.17 | |||||
EV-to-EBITDA | 29944.17 | |||||
EV-to-Revenue | 21.28 | |||||
EV-to-FCF | -151.58 | |||||
FCF Yield % | -1.44 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
China NT Pharma Group Co Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 40.811 | ||
| EPS (TTM) (HK$) | -0.039 | ||
| Beta | 0.178 | ||
| 3-Year Sharpe Ratio | 0.34 | ||
| 3-Year Sortino Ratio | 0.67 | ||
| Volatility % | 75.02 | ||
| 14-Day RSI | 61.61 | ||
| 14-Day ATR (HK$) | 0.03226 | ||
| 20-Day SMA (HK$) | 0.36775 | ||
| 12-1 Month Momentum % | -52.53 | ||
| 52-Week Range (HK$) | 0.3 - 1.35 | ||
| Shares Outstanding (Mil) | 949 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
China NT Pharma Group Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
China NT Pharma Group Co Ltd Stock Events
| Event | Date | Price (HK$) | ||
|---|---|---|---|---|
| 0.1:1 Stock Split | 2024-07-03 | 0.34 (-2.86%) |
Show
Entries
China NT Pharma Group Co Ltd Frequently Asked Questions
What is China NT Pharma Group Co Ltd(HKSE:01011)'s stock price today?
The current price of HKSE:01011 is HK$0.42. The 52 week high of HKSE:01011 is HK$1.35 and 52 week low is HK$0.30.
When is next earnings date of China NT Pharma Group Co Ltd(HKSE:01011)?
The next earnings date of China NT Pharma Group Co Ltd(HKSE:01011) is .
Does China NT Pharma Group Co Ltd(HKSE:01011) pay dividends? If so, how much?
China NT Pharma Group Co Ltd(HKSE:01011) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on China NT Pharma Group Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers